Articles

Meal sequencing may decrease glucose levels and insulin utilization.

Increased cardio risk of Saxagliptin found during trial prompts FDA decision.

Trial results promising, but DKA still a concern with use of new once-daily pills.

Philadelphia youth see rise in diagnosis; especially for African Americans, by 70%.

Common osteoarthritis treatment may be beneficial in lowering HbA1c.

Global healthcare company Novo Nordisk, renewed its partnership with Team Novo Nordisk for an additional two years, extending the company’s commitment to the world’s first all-diabetes professional cycling team to a total of seven years.

New study finds lower occurrence of heart failure in older people with type 2.

Real-time monitoring produces significant long-term improvement in HbA1c.

Study examined effectiveness of CGM on maternal glucose control and obstetric and neonatal health outcomes.

The pendulum has swung from too much fat to too many carbs.